
Summary for Tradename: Lipitor
|
|
Latest news for LIPITORPipeline Checkup: Pfloundering Pfizer29 July 2010, 7:49 pm AstraZeneca 2Q profit up 22 pct29 July 2010, 7:23 am AstraZeneca 2Q profit up 22 pct29 July 2010, 7:00 am AstraZeneca Q2 Profits up 22 Pct29 July 2010, 3:14 am Classic style for all aspects of McKinney practice29 July 2010, 1:46 am AstraZeneca Wins Backing on Drug to Rival Plavix and Replace Aging Drugs28 July 2010, 7:37 pm Do You Use Canadian Pharmacies On The Web?28 July 2010, 12:46 pm Patent firm blazes trail with new drugs app for the iPad28 July 2010, 5:57 am Business briefs26 July 2010, 6:51 am Courtesy of Yahoo News |
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | LIPITOR | atorvastatin calcium | 020702 | Apr 7, 2000 | RX | Yes | Mar 2, 2010 | |||||
| Pfizer | LIPITOR | atorvastatin calcium | 020702 | Apr 7, 2000 | RX | Yes | 4,681,893*PED | Y | Mar 24, 2010 | |||
| Pfizer | LIPITOR | atorvastatin calcium | 020702 | Apr 7, 2000 | RX | Yes | 5,273,995*PED | Y | Jun 28, 2011 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.